Kyverna Therapeutics, Inc.
KYTX
$8.17
$0.091.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.79% | -2.56% | -2.35% | -46.78% | -38.86% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 164.72% | 3.56% | 57.94% | 0.00% | 2.47% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -3.63% | -2.39% | -2.63% | -46.24% | -38.56% |
|
|
|||||
| Total Current Assets | -3.63% | -2.39% | -2.63% | -46.24% | -38.56% |
| Net Property, Plant & Equipment | 22.56% | 10.56% | -49.15% | -44.46% | -39.41% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -13.23% | 32.47% | 60.98% | 142.17% | 157.64% |
| Total Assets | -2.95% | -1.39% | -3.55% | -44.82% | -37.62% |
|
|
|||||
| Total Accounts Payable | -70.42% | 36.96% | 14.75% | -69.63% | 104.01% |
| Total Accrued Expenses | -30.24% | -24.25% | 8.02% | 58.68% | 78.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -57.33% | -44.63% | 0.74% | -6.26% | -7.60% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -42.69% | -10.87% | 8.09% | 9.31% | 69.47% |
|
|
|||||
| Total Current Liabilities | -42.69% | -10.87% | 8.09% | 9.31% | 69.47% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 181.34% | 107.52% | -92.56% | -74.27% | -61.79% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 28.82% | 67.67% | 61.73% | -3.50% | 42.30% |
|
|
|||||
| Common Stock & APIC | 25.05% | 24.06% | 23.96% | 1.96% | 1.82% |
| Retained Earnings | -43.58% | -50.75% | -61.21% | -71.23% | -82.85% |
| Treasury Stock & Other | -610.00% | -9,500.00% | -7.62% | -81.05% | 45.95% |
| Total Common Equity | -10.21% | -12.69% | -12.87% | -49.80% | -44.72% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.21% | -12.69% | -12.87% | -49.80% | -44.72% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.21% | -12.69% | -12.87% | -49.80% | -44.72% |
|
|
|||||